TY - JOUR
AU - K. L. Dugosh
AU - M. R. Lent
AU - S. B. Burkley
AU - C. M. K. Millard
AU - J. R. McKay
AU - K. M. Kampman
A1 - 
AD - From the Research and Evaluation Group, Public Health Management Corporation, Philadelphia, PA (KLD, SBB, CMKM); School of Professional and Applied Psychology, Philadelphia College of Osteopathic Medicine, Philadelphia, PA (MRL); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA (JRM, KMK).
AN - 37788620
BT - J Addict Med
C5 - Opioids & Substance Use
CP - 5
DA - Sep-Oct 01
DO - 10.1097/adm.0000000000001168
DP - NLM
ET - 20230418
IS - 5
JF - J Addict Med
LA - eng
PY - 2023
SN - 1932-0620 (Print); 1932-0620
SP - 612
EP - 614+
ST - Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment
T1 - Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment
T2 - J Addict Med
TI - Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment
U1 - Opioids & Substance Use
U3 - 10.1097/adm.0000000000001168
VL - 17
VO - 1932-0620 (Print); 1932-0620
Y1 - 2023
ER -